<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04229628</url>
  </required_header>
  <id_info>
    <org_study_id>2019364H(R1)</org_study_id>
    <nct_id>NCT04229628</nct_id>
  </id_info>
  <brief_title>Hypertension and Diabetes Mellitus Community Management Center(HAD-COME) Project</brief_title>
  <official_title>Establishment of Hypertension and Diabetes Mellitus Community Management Center(HAD-COME) Project</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangdong Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangdong Provincial People's Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To develop and implement quality improvement programs for the treatment and management of
      hypertension and diabetes,and preventing and controlling hypertension and diabetes-related
      diseases in Chinese community. This program will use data collection, analysis, feedback, and
      process improvement to extend the use of evidence-based guidelines throughout the healthcare
      system and improve patient care of hypertension and diabetes in Chinese community.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this project was to improving care for hypertension and diabetes mellitus in
      Chinese community. Study population including subjects who are hypertension and/or diabetes
      mellitus, of any race or ethnicity, any age.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of community hypertension patients receiving treatment as Chinese guideline recommended</measure>
    <time_frame>at the time of enrollment</time_frame>
    <description>Proportion of community hypertension patients receiving treatment as Chinese guideline recommended at the time of enrollment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of community diabetes mellitus patients receiving treatment as Chinese guideline recommended</measure>
    <time_frame>at the time of enrollment</time_frame>
    <description>Proportion of community diabetes mellitus patients receiving treatment as Chinese guideline recommended at the time of enrollment</description>
  </primary_outcome>
  <enrollment type="Anticipated">100000</enrollment>
  <condition>Hypertension</condition>
  <condition>Diabetes Mellitus</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No special intervention</intervention_name>
    <description>No special intervention</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      This study will collect 10 mL whole blood samples from subjects at one or more study visits.
      The whole blood will be processed to plasma, serum and stored for testing.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Hypertension Diabetes mellitus
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  In accordance with the diagnosis of essential hypertension;

          -  In accordance with the diagnosis of type 2 diabetes mellitus.

        Exclusion Criteria:

          -  Non-type 2 diabetes patients

          -  Secondary hypertension

          -  Non-hypertensive patients

          -  Type 1 diabetes or other types of diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Feng Ying-qing, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Guangdong Provincial People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Feng Ying-qing, PhD</last_name>
    <phone>+862083827812</phone>
    <email>651792209@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Guangdong Provincial People's Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>FENG Yi ng-qing, PhD</last_name>
      <phone>+862083827812</phone>
      <email>651792209@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>January 12, 2020</study_first_submitted>
  <study_first_submitted_qc>January 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2020</study_first_posted>
  <last_update_submitted>January 12, 2020</last_update_submitted>
  <last_update_submitted_qc>January 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

